NCT05882773View on ClinicalTrials.gov

Asian Myeloproliferative Neoplasm (MPN) Registry

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 31, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

December 31, 2026

Conditions
Myeloproliferative NeoplasmPolycythemia VeraEssential ThrombocythemiaPost-polycythemia Vera MyelofibrosisPost-essential Thrombocythemia MyelofibrosisPrimary MyelofibrosisPrimary Myelofibrosis, Prefibrotic StagePrimary Myelofibrosis, Fibrotic Stage
Trial Locations (1)

Unknown

RECRUITING

Department of Medicine, Queen Mary Hospital, Hong Kong

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

The University of Hong Kong

OTHER

NCT05882773 - Asian Myeloproliferative Neoplasm (MPN) Registry | Biotech Hunter | Biotech Hunter